Ivermectin to be investigated in adults aged 18+ as a possible treatment for COVID-19 in the PRINCIPLE trial — PRINCIPLE Trial
Oxford University plans trials of 'wonder drug' that may reduce covid deaths | Mint
Ivermectin treatment in humans for COVID-19 | LSTM
Ivermectin — front-line doctors vs bureaucrats
Ivermectin shows 'antiviral effect' against COVID, Japanese company says | Reuters
Ivermectin frenzy: the advocates, anti-vaxxers and telehealth companies driving demand | Coronavirus | The Guardian
COVID-19 Patients: Oxford University explores anti-parasitic drug ivermectin as Covid-19 treatment, ET HealthWorld
Ivermectin to be investigated in adults aged 18+ as a possible treatment for COVID-19 in the PRINCIPLE trial — PRINCIPLE Trial
Oxford scientists to study ivermectin's efficacy for Covid treatment
In Re-Analysis, Ivermectin Benefits Disappeared as Trial Quality Increased | MedPage Today
Oxford University explores anti-parasitic drug ivermectin as Covid-19 treatment | World News - Hindustan Times
First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy — University of Oxford, Medical Sciences Division
Desperation, misinformation: how the ivermectin craze spread across the world | Coronavirus | The Guardian
Oxford University explores anti-parasitic drug ivermectin as COVID-19 treatment | Reuters
Ivermectin: Northern Ireland seizures of unproven drug used for Covid - BBC News
Ivermectin to be Investigated As Possible Treatment for COVID-19
How the ivermectin culture wars took off : Shots - Health News : NPR
Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial - The Lancet
Study supports evidence ivermectin not effective to treat COVID-19 — University of Oxford, Medical Sciences Division
DOH, DOST, and PCHRD terminate conduct of Ivermectin clinical trial for COVID-19 | Philippine Council for Health Research and Development
Israeli scientist says COVID-19 could be treated for under $1/day - The Jerusalem Post
Ivermectin for COVID-19 review update: 11 trials and no evidence of benefit shown | LSTM
